ACRVAcrivon Therapeutics, Inc.
Insider trading & SEC Form 4 activity — last 90 days. Latest filing: 2026-05-26.
Insider buys (90d)
$0.00
Insider sells (90d)
$0.00
Net flow
$0.00
Filings
22
Buy transactions
0
Sell transactions
0
Distinct insiders
19
Last close (cached)
$1.41
as of 2026-06-08
1d return
-1.4%
5d return
-9.6%
1m return
-30.5%
Top insiders trading ACRV (90d)
Recent transactions (37)
| Filed | Txn date | Insider | Code | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | 2026-05-21 | Blume-Jensen Peter | Tax | 13,729 | $1.79 | $24.6K | open → |
| 2026-05-26 | 2026-05-21 | Masson Kristina | Tax | 13,729 | $1.79 | $24.6K | open → |
| 2026-05-20 | 2026-05-18 | RA CAPITAL MANAGEMENT, L.P. | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | RA Capital Healthcare Fund LP Director10% | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | RA Capital Nexus Fund II, L.P. Director | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Kolchinsky Peter Director10% | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Shah Rajeev M. Director10% | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | TOMSICEK MICHAEL JOHN | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Shacham Sharon | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Palani Santhosh | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Magovcevic-Liebisch Ivana | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | DiRocco Derek | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | BAUM CHARLES M | Grant | 9,366 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Peterson Katharine | Grant | 14,227 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Mirza Mansoor Raza | Grant | 38,817 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Miller Mary | Grant | 49,830 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Levy Adam D. | Grant | 46,167 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Gamelin Erick | Grant | 38,584 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Devroe Eric | Grant | 72,981 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Masson Kristina | Grant | 72,706 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Blume-Jensen Peter | Grant | 72,706 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Masson Kristina | Grant | 180,095 | $0.00 | $0.00 | open → |
| 2026-05-20 | 2026-05-18 | Blume-Jensen Peter | Grant | 180,095 | $0.00 | $0.00 | open → |
| 2026-05-18 | 2026-05-14 | Peterson Katharine | Tax | 99 | $1.92 | $190.08 | open → |
| 2026-05-18 | 2026-05-14 | Miller Mary | Tax | 184 | $1.92 | $353.28 | open → |
| 2026-05-18 | 2026-05-14 | Gamelin Erick | Tax | 404 | $1.92 | $775.68 | open → |
| 2026-05-18 | 2026-05-14 | Devroe Eric | Tax | 613 | $1.92 | $1.2K | open → |
| 2026-05-18 | 2026-05-14 | Masson Kristina | Tax | 490 | $1.92 | $940.80 | open → |
| 2026-05-18 | 2026-05-14 | Blume-Jensen Peter | Tax | 490 | $1.92 | $940.80 | open → |
| 2026-05-18 | 2026-05-14 | Masson Kristina | Tax | 1,253 | $1.92 | $2.4K | open → |
| 2026-05-18 | 2026-05-14 | Blume-Jensen Peter | Tax | 1,253 | $1.92 | $2.4K | open → |
| 2026-04-23 | 2026-04-22 | RA CAPITAL MANAGEMENT, L.P. | Grant | 3,888,888 | $1.80 | $7.00M | open → |
| 2026-04-23 | 2026-04-22 | RA Capital Healthcare Fund LP Director10% | Grant | 3,888,888 | $1.80 | $7.00M | open → |
| 2026-04-23 | 2026-04-22 | RA Capital Nexus Fund II, L.P. Director | Grant | 3,888,888 | $1.80 | $7.00M | open → |
| 2026-04-23 | 2026-04-22 | Kolchinsky Peter Director10% | Grant | 3,888,888 | $1.80 | $7.00M | open → |
| 2026-04-23 | 2026-04-22 | Shah Rajeev M. Director10% | Grant | 3,888,888 | $1.80 | $7.00M | open → |
| 2026-04-21 | 2026-04-17 | Miller Mary | Tax | 558 | $1.78 | $993.24 | open → |
Other tickers these insiders trade
Want an email the moment a new insider transaction is filed on ACRV? Set up an alert → Watch4Insider delivers SEC Form 4 alerts with a sub-60s p95 SLA.
